Related references
Note: Only part of the references are listed.Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db Mice
Mohan R. Dasu et al.
ENDOCRINOLOGY (2009)
Activation of peroxisome proliferator-activated receptor γ inhibits TNF-α-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression
Hiroyuki Hounoki et al.
BONE (2008)
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Ramya Kapadia et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists
Antonietta Bernardo et al.
PPAR RESEARCH (2008)
PPAR-γ:: therapeutic target for ischemic stroke
Juraj Culman et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Effect of PPARα activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes
Kentaro Murakami et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse
Rashmi Kumari et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Effects of peroxisome proliferator-activated receptors on a lipoprotein metabolism and glucose control in type 2 diabetes mellitus
Robert S. Rosenson
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents
Kudret Tureyen et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Psychoneuroimmune implications of type 2 diabetes
Jason C. O'Connor et al.
NEUROLOGIC CLINICS (2006)
Peroxisome proliferator-activated receptor agonist regulation of glial activation: Relevance to CNS inflammatory disorders
Paul D. Drew et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats
Yi Zhao et al.
FASEB JOURNAL (2006)
Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
YM Luo et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms
MP Pereira et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice
T Harrity et al.
DIABETES (2006)
Intermittent hypoxia induces hyperlipidemia in lean mice
JG Li et al.
CIRCULATION RESEARCH (2005)
A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia
T Shimazu et al.
STROKE (2005)
Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia
S Sundararajan et al.
NEUROSCIENCE (2005)
Increased glucocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice
YJ Liu et al.
DIABETES (2005)
The diabetes epidemic: A national and global crisis
RO Bonow et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Stress responses and innate immunity: aging as a contributory factor
SK Butcher et al.
AGING CELL (2004)
Glucocorticoids: Protectors of the brain during innate immune responses
I Glezer et al.
NEUROSCIENTIST (2004)
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice
E Bernotiene et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice
LQ Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mechanism and implications of brown adipose tissue proliferation in rats and monkeys treated with the thiazolidinedione darglitazone, a potent peroxisome proliferator-activated receptor-γ agonist
MD Aleo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The many faces of tumor necrosis factor in stroke
JM Hallenbeck
NATURE MEDICINE (2002)
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability
ND Oakes et al.
DIABETES (2001)
Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity
J Berger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Experimental stroke in the female diabetic, db/db, mouse
SJ Vannucci et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Central nervous system-initiated inflammation and neurotrophism in trauma:: IL-1β is required for the production of ciliary neurotrophic factor
LM Herx et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
